Table 2.
Effect of resveratrol on age-related diseases.
Study type | Subjects | Administration methods | Dose & duration | Effects and mechanisms | Ref. |
---|---|---|---|---|---|
Neurodegenerative diseases | |||||
In vivo | C57BL/6J mice | Intraventricular injection | 5 μg/μL for 1 week | Improved learning and memory functions in a Sirt1-dependent way | [33] |
In vivo | Aged C57BL/6 mice | Oral administration | 200 mg/kg for 10 days | Rescued cortical neurovascular coupling responses to improve neuronal activity and function by restoring cerebromicrovascular endothelial function and decreasing ROS production | [65] |
In vivo | C57BL/6 mice | Intraperitoneal injection | 100 mg/kg for 7 days | Alleviated the hippocampus-dependent cognitive impairment via anti-inflammation and antiapoptosis actions | [66] |
In vivo | Male F344 rats | Intraperitoneal administration | 40 mg/kg for 4 weeks | Improved memory and mood functions, increased hippocampal neurogenesis and microvasculature, and reduced glial activation | [34] |
In vivo | Old male rats | Chronic administration | 20 mg/kg for 4 weeks | Improved cognitive impairment by enhancing the secretion of neurotransmitters (serotonin, noradrenaline, and dopamine), which is largely due to the increased activities of TPH and TH | [35] |
In vitro, in vivo | Adult hippocampal precursor cells; female Balb/C mice | Cell culture; injection | 40 mg/kg for 2 weeks | Induced neuronal differentiation in adult hippocampal precursor cells without effects on proliferation in vitro, improved behavioral performance, increased production of new neurons, elevated population of doublecortin-expressing intermediate cells, and promoted hippocampal neurogenesis in vivo through the phospho-Akt and phosphoprotein kinase C signaling pathways | [32] |
In vivo | Aged Sprague-Dawley rats | Intraperitoneal injection | 100 mg/kg for 7 days | Inhibited neuronal apoptosis and improved behavioral performance via Sirt1-p53 signaling pathway | [67] |
In vivo | Male Wistar rats | Oral administration | 50 mg/kg for 12 weeks | Improve aging-induced emotional and spatial learning memory impairment via inhibiting inflammation | [36] |
In vitro, in vivo | SH-SY5Y neuroblastoma cells; male C57BL/6 mice | Cell culture; feeding | 1 or 5 μM; 120 mg/kg | Alleviated age-related motor decline and exerted neuroprotection via the promotion of dopamine neuronal survival and activation of the ERK1/2 pathways | [68] |
Cardiovascular disease | |||||
In vitro | Aging endothelial cells; aortas of old WKY rats | Cell and tissue culture | 10 μmol/L | Inhibited S6K1 signaling, reduced superoxide generation, and enhanced NO levels | [39] |
In vivo | Senescence-accelerated mice prone 8 (SAMP8) | Intraperitoneal injection | 20 mg/kg for 3 days | Attenuated doxorubicin-induced cardiotoxicity through restoring the activity of Sirt1 | [42] |
In vivo, in vitro | Aged male C57BL/6 mice; vascular smooth muscle cells | Dietary supplementation | 40 mg/kg for 6 months | Lowered aorta media thickness, inflammation, fibrosis, and oxidative stress and protected against arterial aging through modulating the activity of the renin-angiotensin system | [43] |
In vivo | Wistar albino rats | Drinking water | 0.05 mg/mL for 6 weeks | Altered vessel responsiveness and biomarkers related to vascular functions | [69] |
In vitro | Human umbilical vein endothelial cells | Cell culture | 10 μM | Enhanced the cell viability and SOD levels, inhibited the increased levels of senescence-associated β-galactosidase and intracellular ROS induced by H2O2 treatment, and upregulated autophagy | [40] |
In vitro | Thoracic aorta of aged Wistar rats | Organ culture | 30 μM for 4 h or 24 h | Improved methylglyoxal-induced endothelial dysfunction by increasing eNOS expression and activity | [41] |
Sarcopenia | |||||
In vivo | Fischer 344 x Brown Norway rats | Dietary supplementation | 50 mg/kg for 6 weeks | Protected against aging-induced muscle loss via modestly altered key mitochondrial regulatory and apoptotic signaling pathways in glycolytic muscle | [47] |
In vivo | Fischer 344 x Brown Norway rats | Oral gavage | 125 mg/kg | Improved muscle mass, increased the fiber cross-sectional area of type IIA and IIB fibers during reloading after hindlimb suspension due to decreases in the abundance of proapoptotic proteins | [48] |
In vivo | Aged C57BL/6J mice | Oral gavage | 25 mg/kg BW for 4 weeks | Resveratrol combined with exercise training showed stronger muscle strength and endurance performance of aged mice than the resveratrol or exercise training alone | [49] |
In vivo | Aged male Sprague-Dawley rats | Dietary supplementation | 150 mg/kg for 6 weeks | Increased the relative grip strength and muscle mass and reduced the increment in sarcomere length, I-band, and H-zone via antiapoptotic signaling pathways through the activation of AMPK/Sirt1 | [51] |
In vivo | C57/BL6 mice | Dietary supplementation | 0.04% for 6 months | Inhibited tubular aggregates and showed better resistance to fatigue | [70] |
In vivo | C57BL/6J male mice | Dietary supplementation | 0.04% for 6 months | Showed a better fatigue resistance | [71] |
Cancers | |||||
In vitro | Ovarian cancer cells | Cell culture | 25-800 μM | Suppressed proliferation and evoked apoptosis via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway | [53] |
In vitro | Gastric cancer cell | Cell culture | 0, 25, 50, and 100 μM for 96 h | Inhibited cell proliferation and survival through inhibition of PIM-1 kinase activity | [54] |
In vitro | Human prostate cancer cell lines | Cell culture | 50 μM for 48 h | Inhibited cell proliferation and migration through the NF-κB pathway | [55] |
In vitro, in vivo | Colon cancer cells; nude mice | Cell culture; intraperitoneal injection | 0-240 μmol/L; 150 mg/kg BW | Inhibited invasion and metastasis through the reversal of EMT via the Akt/GSK-3 β/Snail signaling pathway | [56] |
In vitro | Human colon cancer cell lines | Cell culture | 0-50 μM | Inhibited cell viability, induced apoptosis, and decreased expression of cyclooxygenase-2 and prostaglandin receptor | [57] |
In vitro | Prostate cancer cells | Cell culture | 25-100 μM | Inhibited proliferation and promoted apoptosis | [58] |
Other diseases | |||||
In vitro | Mouse oocytes | Cell culture | 1 μM | Improved the quality of postovulatory aging oocytes via maintaining mitochondrion distribution and the normal morphology of spindle, alleviating oxidative stress, ameliorating apoptosis, and decreasing the loss of sperm binding | [60] |
In vivo | Female C57BL/6 mice | Drinking water | 30 mg/L for 6 or 12 months | Reserved the ability of reproduction and showed a larger follicle pool, improved the number and quality of oocytes, telomerase activity, telomere length, and age-related gene expression in ovaries | [61] |
In vivo | Aged male Wistar rats | Drinking water | 10 mg/kg for 10 weeks | Increased bone volume, bone trabecular number, and cortical thickness and reduced spacing between trabeculae | [63] |
In vivo | C57BL/6 mice | Dietary supplementation | 300 mg/kg for 10 weeks | Accelerated osteoblast activity and bone growth, and promoted bone formation in a Sirt1-dependant way | [64] |
Note: Sirt1: sirtuin1; ROS: reactive oxygen species; TPH: tryptophan hydroxylase; TH: tyrosine hydroxylase; Akt: protein kinase B; ERK1/2: extracellular-regulated kinases 1 and 2; S6K1: ribosomal protein S6 kinase, polypeptide1; NO: nitric oxide; SOD: superoxide dismutase; eNOS: endothelial nitric oxide synthase; AMPK: 5′-monophosphate-activated protein kinase; mTOR: mammalian target of rapamycin; PIM-1 kinase: proviral integration site for Moloney murine leukemia virus-1 kinase; BW: body weight; NF-κB: nuclear-factor kappa B; EMT: epithelial-mesenchymal transition; Akt/GSK-3 β/Snail: protein kinase B/glycogen synthase kinase-3 β/Snail signaling.